ArticleNPJ breast cancer2017
The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening.
Article in NPJ breast cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
92 citing papers in PubMed, 4 syntheses or guidelines pooled it, 218 citations in OpenAlex.
- Interval breast cancer rates for tomosynthesis vs mammography population screening: a systematic review and meta-analysis of prospective studies.European radiology · 2025Pooled it
- The Impact of Breast Density Information or Notification on Women's Cognitive, Psychological, and Behavioral Outcomes: A Systematic Review.Journal of the National Cancer Institute · 2021Pooled it
- Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy.BMJ (Clinical research ed.) · 2021Pooled it
- [Breast cancer screening and diagnosis at the end of the COVID-19 confinement period, practical aspects and prioritization rules: recommendations of 6 French health professionals societies].Bulletin du cancer · 2020Guideline
- AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trial.Nature medicine · 2024Trial
- Location of AI risk markers and associated mammographic features in screening mammograms obtained years before screen-detected breast cancer.European radiology · 2026Article
- A comparison of tumour characteristics of screen-detected and interval cancers and their relationship with breast density and AJCC prognostic stage in a UK screening cohort.European radiology · 2026Article
- Applications of Artificial Intelligence in Cancer Diagnosis and Treatment.Cancer medicine · 2026Review
- Isolated Regional Nodal Recurrence After Primary Breast Cancer: Risk Factors and Survival by Mode of Detection.Journal of breast cancer · 2026Article
- Performance across different versions of an artificial intelligence model for screen-reading of mammograms.European radiology · 2026Article
- Interval Cancers after Negative Screening Contrast-enhanced Mammography.Radiology. Imaging cancer · 2026Article
- Retrospective evaluation of interval breast cancer screening mammograms by radiologists and AI.European radiology · 2026Article
- Factors associated with receipt of surveillance breast MRI among racially and ethnically diverse women with operable breast cancer.Breast cancer research and treatment · 2025Article
- Article
- Retrospective evaluation of a CE-marked AI system, including 1,017,208 mammography screening examinations.European radiology · 2025Article
- Thirty years of population-based breast cancer screening in Iceland: a comparison of quality indicators and tumour characteristics between women aged 40-49 and 50-69 years.Acta oncologica (Stockholm, Sweden) · 2025Article
- Mammographic classification of interval breast cancers and artificial intelligence performance.Journal of the National Cancer Institute · 2025Article
- Tumour growth rate and invasive interval cancer characteristics in a UK breast cancer screening population.European radiology · 2025Article
- Extending catchment area approaches to a community cancer center: a breast cancer hotspot case study.JNCI cancer spectrum · 2025Article
- Article
32 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.